Editorial Commentary: Outcomes and Complication Risk in Type 1 Diabetic Patients Undergoing Hip Arthroscopy-Diabetes is NOT a Single Disease

As the utilization of hip arthroscopy continues to grow, there is greater attention being paid to the effect of comorbidities on complication risk and outcomes. Some variables, such as body mass index and age, have been studied extensively with respect to their impact on outcomes following hip arthroscopy, while the impact of other systemic medical conditions is less well understood. While it is true that published studies looking at the impact of diabetes and hip arthroscopy have not shown a significant difference compared with non-diabetic controls, the studies do not differentiate between type 1 diabetes mellitus and type 2 diabetes mellitus. This is an important distinction, because although there is much overlap in the clinical presentation of these closely related disease states, patients with type 1 diabetes mellitus tend to have lower body mass index and many have associated autoimmune conditions that can also complicate recovery from arthroscopic hip surgery.